Software Advanced Process Modelling Software

Editor: Ahlam Rais

Process Systems Enterprise (PSE), a Siemens Business, has announced the full release of Gproms Formulated Products 2.0, the mechanistic model-based environment for integrated digital design of robust formulated products and their manufacturing processes, and related digital process operation.

Related Companies

Gproms Formulated Products 2.0 is a mechanistic model-based environment for integrated digital design of robust formulated products and their manufacturing processes, and related digital process operation.
Gproms Formulated Products 2.0 is a mechanistic model-based environment for integrated digital design of robust formulated products and their manufacturing processes, and related digital process operation.
(Source: Business Wire)

The release at the 2021 Advanced Process Modelling Forum follows an early release to key customers, and reflects the substantial investment Siemens is making into PSE’s product development to provide the process industries with a new generation of digital tools.

Version 2.0 introduces major enhancements to both the Gproms Formulated Products model libraries and the underlying Gproms platform 7.0, such as surrogate modelling. Additions include new mechanistic model libraries for developing bioprocess digital twins of bioreactor, membrane filtration and chromatography processes, and a new mechanistic canine model for the design, virtual formulation prototyping and risk analysis of clinical and pre-clinical drug product formulations, states the company.

Version 2.0 also introduces key library enhancements in active ingredient manufacture, formulation manufacture and product performance. Workflows when specifying buffers and media compositions of in vitro vessel, solution and suspension dosage forms have been streamlined, and equilibrium limited reactions added to the chemical synthesis libraries. Additionally, this release includes many usability and robustness enhancements to provide an improved user experience, such as a new case file structure, streamlined data import workflows using a new experiment data manager, parallel multi-start optimization and parameter estimation, and new cross-disciplinary examples and templates that can directly be customized to users’ projects, adds the firm.

The company is working closely with major users in pharma, F&B, FMCG, specialty chemicals and mining, with their requirements driving its extensive development program.

(ID:47378576)